Aadi Bioscience, Inc.AADINASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank26
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P26
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -12.44% |
| Q2 2025 | -53.65% |
| Q1 2025 | 15.96% |
| Q4 2024 | 53.79% |
| Q3 2024 | -8.95% |
| Q2 2024 | -25.69% |
| Q1 2024 | 2.66% |
| Q4 2023 | -7.81% |
| Q3 2023 | -4.71% |
| Q2 2023 | 5.08% |
| Q1 2023 | 0.91% |
| Q4 2022 | 12.01% |
| Q3 2022 | -0.91% |
| Q2 2022 | 9.38% |
| Q1 2022 | -5.87% |
| Q4 2021 | 31.31% |
| Q3 2021 | 82.66% |
| Q2 2021 | 89.63% |
| Q1 2021 | -11.18% |
| Q4 2020 | 28.26% |
| Q3 2020 | 255.59% |
| Q2 2020 | -21.56% |
| Q1 2020 | -56.36% |
| Q4 2019 | -28.70% |
| Q3 2019 | -22.82% |
| Q2 2019 | -13.99% |
| Q1 2019 | -10.07% |
| Q4 2018 | 10.44% |
| Q3 2018 | 4.35% |
| Q2 2018 | -8.90% |
| Q1 2018 | 37.44% |
| Q4 2017 | 38.29% |
| Q3 2017 | -24.88% |
| Q2 2017 | -3.56% |
| Q1 2017 | 15465.36% |
| Q4 2016 | 270.67% |
| Q3 2016 | -14.95% |
| Q2 2016 | -99.58% |
| Q1 2016 | 12548.34% |
| Q4 2015 | 122.11% |